Clinical Trial

Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma

Name: Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma — clinical trial record (NCT07536789)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study will evaluate the efficacy and safety of Becotatug vedotin, MRG003, in previously treated advanced hepatocellular carcinoma (HCC).

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-22

Trial Details

NCT Number	NCT07536789
Lead Sponsor	Fudan University
Conditions	Hepato Cellular Carcinoma (HCC)
Enrollment	40 participants
Start Date	2026-04-17
Primary Completion	2028-04-15 (estimated)
Study Completion	2029-04-14 (estimated)
Updated on ClinicalTrials.gov	2026-04-21